Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00282048
Status:
COMPLETED
Last Update Posted:
2012-07-31
First Post:
2006-01-23
Brief Title:
Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Phase 2 Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer
Status:
COMPLETED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the activity and response rate of AG-013736 in patients with advanced and refractory renal cell cancer patients who also failed on sorafenib-based therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None